Seventh Wave: Acquisition Costs Lead to Loss for BASi

West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is reporting a fiscal third quarter net loss of $75,000, compared to net income of $227,000 during the same period last year. Chief Financial Officer Jill Blumhoff says the earnings were negatively affected by costs related to the company's July acquisition of Missouri-based Seventh Wave Laboratories LLC.